VITASPRING BIOMEDICAL CO., LTD. Accumulated Amortization, Debt Issuance Costs
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Accumulated Amortization, Debt Issuance Costs of $7.13 thousand as of 2024-01-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes
us-gaap:AccumulatedAmortizationDeferredFinanceCosts · last filed 2026-03-12
- 2024-01-31: Accumulated Amortization, Debt Issuance Costs $7.13K.
- 2023-12-31: Accumulated Amortization, Debt Issuance Costs $5.90K.
- 2023-01-31: Accumulated Amortization, Debt Issuance Costs $5.90K.
- 2022-12-31: Accumulated Amortization, Debt Issuance Costs $6.94K.
| Period end | Accumulated Amortization, Debt Issuance Costs |
|---|---|
| 2024-01-31 | $7.13K 10-K · filed 2026-03-12 |
| 2023-12-31 | $5.90K 10-K · filed 2025-12-01 |
| 2023-01-31 | $5.90K 10-K · filed 2026-03-12 |
| 2022-12-31 | $6.94K 10-K · filed 2025-12-01 |